Enanta Pharmaceuticals
ENTA
#8970
Rank
C$0.15 B
Marketcap
$7.40
Share price
3.21%
Change (1 day)
-55.91%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2024 (TTM): -C$0.15 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are C$67.63 Million. In 2023 the company made an earning of -C$0.19 Billion a decrease over its 2022 earnings that were of -C$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.15 Billion-21.5%
2023 -C$0.19 Billion4.39%
2022 -C$0.18 Billion-4.4%
2021 -C$0.19 Billion91.12%
2020 -C$96.23 Million-407.13%
2019 C$31.33 M-78.63%
2018 C$0.14 B117.97%
2017 C$67.27 M-574.65%
2016 -C$14.18 Million-110.83%
2015 C$0.13 B-4.5%
2014 C$0.13 B-638.53%
2013 -C$25.46 Million-137.98%
2012 C$67 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$10.36 B-6,835.74%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.49 B-17,316.05%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.42 B-378.90%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.56 B-14,113.36%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.91 Billion 6,339.05%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.33 B-12,015.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland